Literature DB >> 6168692

Specific unresponsiveness to skin allografts in anti-lymphocyte serum-treated, marrow-injected mice: participation of donor marrow-derived suppressor T cells.

T Maki, R Gottschalk, M L Wood, A P Monaco.   

Abstract

Sequential changes of cell-mediated immune reactivities were examined in anti-lymphocyte serum-(ALS) treated, C3H/He (C3H; H-2k) bone marrow-injected (C57BL/6 X A)F1 (B6AF1; H-2b/k.d) mice bearing enhanced C3H skin grafts. Spleen cells of these mice exhibited marked suppression of the proliferative response to phytohemagglutinin and concanavalin A. When the spleen cells were assayed for the direct lymphocyte-mediated cytotoxicity against H-2k targets, their lytic activity remained low until the time of graft rejection, in contrast to the increasingly high cytotoxic activity exhibited by spleen cells of control B6AF1 mice given only ALS and C3H skin grafts. When spleen cells of marrow-injected B6AF1 mice were cultured with mitomycin-C treated C3H spleen cells, the proliferative response was significantly suppressed the throughout the course, despite the early appearance of high "secondary-type" cytotoxic activity. Co-culture experiments demonstrated the presence of C3H antigen-specific suppressor cells in the ALS-treated, marrow-injected mice bearing intact allografts. Treatment of spleen cells with anti-H-2, anti-Thy 1 and anti-I-J sera and C revealed that the suppressor cells present late in the marrow-injected mice were T cells of donor C3H bone marrow cell origin.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6168692

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Induction of Pancreatic Islet Graft Acceptance: The Role of Antigen Presenting Cells.

Authors:  Camillo Ricordi; Suzanne T Ildstad; Thomas E Starzl
Journal:  Transplant Sci       Date:  1992-04

Review 2.  The role of cell migration and microchimerism in the induction of tolerance after solid organ transplantation.

Authors:  R M Jindal; A Sahota
Journal:  Postgrad Med J       Date:  1997-03       Impact factor: 2.401

3.  Ex vivo preservation and expansion of human limbal epithelial stem cells on amniotic membrane cultures.

Authors:  D Meller; R T F Pires; S C G Tseng
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

4.  Investigation of the mechanism of active enhancement of renal allograft survival by blood transfusion.

Authors:  R L Quigley; K J Wood; P J Morris
Journal:  Immunology       Date:  1988-03       Impact factor: 7.397

Review 5.  Use of donor bone marrow cells for the induction of specific allograft prolongation.

Authors:  J J Gozzo
Journal:  Surv Immunol Res       Date:  1982

6.  Long-term abrogation of autoimmune diabetes in nonobese diabetic mice by immunotherapy with anti-lymphocyte serum.

Authors:  T Maki; T Ichikawa; R Blanco; J Porter
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

7.  Long-term survival of donor-specific pancreatic islet xenografts in fully xenogeneic chimeras (WF rat----B10 mouse).

Authors:  Y J Zeng; C Ricordi; A Tzakis; H L Rilo; P B Carroll; T E Starzl; S T Ildstad
Journal:  Transplantation       Date:  1992-02       Impact factor: 4.939

8.  Long-term incompatible kidney survival in outbred higher primates without chronic immunosuppression.

Authors:  F T Thomas; F M Carver; M B Foil; W H Pryor; E W Larkin; W R Hall; C E Haisch; J M Thomas
Journal:  Ann Surg       Date:  1983-09       Impact factor: 12.969

9.  Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats.

Authors:  N Murase; T E Starzl; M Tanabe; S Fujisaki; H Miyazawa; Q Ye; C P Delaney; J J Fung; A J Demetris
Journal:  Transplantation       Date:  1995-07-27       Impact factor: 4.939

10.  Cloning of self-major histocompatibility complex antigen-specific suppressor cells from adult bone marrow.

Authors:  T Takahashi; K Mafune; T Maki
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.